Angiographic Restenosis and Clinical Recurrence After Sirolimus- and Paclitaxel-Eluting Stent Implantation
Authors:
- 31 August 2009
- journal article
- editorial
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 2 (8) , 776-778
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparison of the Sirolimus-Eluting Versus Paclitaxel-Eluting Coronary Stent in Patients With Diabetes Mellitus: The Diabetes and Drug-Eluting Stent (DiabeDES) Randomized Angiography Trial††A list of participating centers and investigators appears in the Appendix.The American Journal of Cardiology, 2009
- Heart Disease and Stroke Statistics—2009 UpdateCirculation, 2009
- Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary InterventionNew England Journal of Medicine, 2009
- A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes MellitusJACC, 2008
- Effect of Paclitaxel‐Eluting Versus Sirolimus‐Eluting Stents on Coronary Restenosis in Korean Diabetic PatientsJournal of Interventional Cardiology, 2008
- Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical PracticeJAMA, 2008
- A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery DiseaseJACC, 2007
- The Emperor’s New ClothesJACC, 2007
- Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisThe Lancet, 2007
- Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stentsAmerican Heart Journal, 2007